Skip to main content
. 2020 Sep 14;9(19):e014669. doi: 10.1161/JAHA.119.014669

Table 2.

Characteristics of Hospitalized Patients With Acute HFpEF From the ARIC Community Surveillance Study by Sex and Race

Women (n=5834) Men (n=3153) P Value White Participants (n=6886) Black Participants (n=2101) P Value
Age (mean), y 78.1 (10.1) 75.6 (10.8) <0.001 78.9 (9.3) 71.9 (12.2) <0.001
Men, % 35.3 34.4 0.38
Black participants, % 23.6 22.9 0.38
Admission to teaching hospital, % 33.1 36.6 0.01 35.7 29.8 0.01
History of HF hospitalization, % 26.2 23.8 0.26 22.0 36.4 <0.001
Hypertension, % 90.0 86.3 0.02 87.4 92.8 0.001
Diabetes mellitus, % 47.8 46.2 0.50 42.1 64.1 <0.001
Atrial fibrillation/flutter, % 39.5 41.1 0.51 44.8 24.5 <0.001
Coronary artery disease, % 40.4 51.8 <0.001 45.9 39.3 0.01
Pulmonary hypertension, % 22.8 16.7 0.003 20.4 21.7 0.52
Sleep apnea, % 12.6 21.0 <0.001 14.9 17.7 0.13
COPD, % 38.0 38.0 0.98 38.6 36.2 0.35
End‐stage renal disease, % 4.3 6.9 <0.001 3.6 10.3 <0.001
Heart rate, beats per min 87.5 (23.3) 84.7 (24.0) 0.02 87.1 (22.8) 84.7 (24.9) 0.04
SBP, mm Hg 146.7 (32.0) 146.7 (32.7) 0.99 144.4 (29.1) 154.1 (41.4) <0.001
BMI, kg/m2 31.6 (11.7) 30.6 (8.6) 0.03 30.3 (9.5) 34.6 (14.4) <0.001
Sodium (worst), mmol/L 135.8 (4.6) 136.5 (4.4) 0.002 135.9 (4.3) 136.5 (5.0) 0.02
eGFR (worst), mL/min per 1.73 m2 38.8 (20.7) 42.3 (24.9) 0.002 40.2 (19.4) 39.5 (31.7) 0.56
BNP (worst), pg/mL 981.4 (1970.5) 857.5 (1026.5) 0.15 938.0 (1731.0) 932.7 (1247.7) 0.95
NT‐proBNP (worst), pg/mL 8055.4 (14615.8) 8177.3 (12412.9) 0.94 6726.6 (8139.2) 9843.4 (19357.5) 0.11
Hemoglobin (last), g/dL 11.0 (1.7) 11.5 (2.1) <0.001 11.3 (1.7) 10.8 (2.3) <0.001

Data are reported as number (percentage), mean (SD), or median [interquartile interval]. ARIC indicates Atherosclerosis Risk in Communities; BMI, body mass index; BNP, B‐type natriuretic peptide; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; and SBP, systolic blood pressure.